BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 67 filers reported holding BOLT BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $789,000 | -14.1% | 533,432 | +18.5% | 0.02% | -29.2% |
| Q2 2022 | $918,000 | -92.1% | 450,141 | -81.1% | 0.02% | -88.3% |
| Q4 2021 | $11,654,000 | -61.3% | 2,378,325 | 0.0% | 0.20% | -50.8% |
| Q3 2021 | $30,086,000 | -18.2% | 2,378,325 | 0.0% | 0.42% | -29.3% |
| Q2 2021 | $36,769,000 | -53.0% | 2,378,325 | 0.0% | 0.59% | -50.0% |
| Q1 2021 | $78,271,000 | – | 2,378,325 | – | 1.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hawkeye Capital Management, LLC | 415,039 | $431,641 | 1.06% |
| Nan Fung Group Holdings Ltd | 1,166,952 | $1,213,630 | 0.98% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $1,967,126 | 0.78% |
| TANG CAPITAL MANAGEMENT LLC | 3,557,040 | $3,699,322 | 0.52% |
| Vivo Capital, LLC | 3,871,291 | $4,026,143 | 0.44% |
| Samsara BioCapital, LLC | 1,049,153 | $1,091,119 | 0.33% |
| Acuitas Investments, LLC | 460,379 | $478,794 | 0.28% |
| Newtyn Management, LLC | 1,020,000 | $1,060,800 | 0.26% |
| Sofinnova Investments, Inc. | 2,754,437 | $2,864,614 | 0.18% |
| Privium Fund Management (UK) Ltd | 116,516 | $121,177 | 0.10% |